August 4, 2021   NEWS

Bionomics looks to Nasdaq as its route to growth

MELBOURNE: Peter Thiel-backed anxiety medication developer Bionomics says it’s considering a Nasdaq listing.

The ...

To read the full story...SUBSCRIBE NOW

Existing Subscribers Login Below:

Log In